Renaissance Capital logo

LRTX News

Oncology biotech Lirum Therapeutics changes terms, adds warrants ahead of $25 million IPO

Lirum Therapeutics logo

Lirum Therapeutics, a Phase 1 biotech developing an in-licensed therapy for cancer and autoimmune diseases, revised the terms for its upcoming IPO on Friday. The New York, NY-based company now plans to raise $25 million by offering 5 million shares at $5, as...read more

US IPO Week Ahead: EVs, auto transport, and design software to lead 6 IPO week

ZK

Six listings are currently scheduled for the week ahead, three of which plan to raise over $100 million. Chinese premium EV brand ZEEKR (ZK) plans to raise $341 million at a $4.8 billion market cap. The company was originally part of Chinese...read more

Oncology and autoimmune biotech Lirum Therapeutics sets terms for $25 million IPO

Lirum Therapeutics logo

Lirum Therapeutics, a Phase 1 biotech developing an in-licensed therapy for cancer and autoimmune diseases, announced terms for its IPO on Thursday. The New York, NY-based company plans to raise $25 million by offering 2.3 million shares at a price range of $10...read more

US IPO Weekly Recap: 7 new filers join the pipeline as Reddit and Auna launch

NTHI

No IPOs debuted this past, as two companies previously scheduled to list (NTHI and RAN) kicked the can down the road. Seven IPOs and one SPAC submitted initial filings this week. Meanwhile, social media platform Reddit (RDDT) launched its...read more